Mi Jin Kim

Title: Mi Jin Kim: Innovator in Anticancer Pharmaceutical Composition

Introduction

Mi Jin Kim is a prominent inventor based in Daegu, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at enhancing anticancer effects. Her work is crucial in addressing the challenges faced in treating liver cancer.

Latest Patents

Mi Jin Kim holds a patent for the invention titled "Use of composition for enhancing anticancer effect, comprising ERRγ inhibitor as active ingredient." This innovative pharmaceutical composition is designed to inhibit the resistance of liver cancer to sorafenib, a common treatment, thereby enhancing its anticancer effect. The active ingredient in this composition is an Estrogen-related receptor γ (ERRγ) inhibitor. This invention is particularly valuable for treating sorafenib-resistant advanced liver cancer.

Career Highlights

Mi Jin Kim is associated with Novmetapharma Co., Ltd., where she continues to advance her research and development efforts. Her dedication to improving cancer treatment options has positioned her as a key figure in the pharmaceutical industry.

Collaborations

Mi Jin Kim has worked alongside notable colleagues, including Keun Gyu Park and In Kyu Lee. Their collaborative efforts contribute to the innovative research being conducted at Novmetapharma Co., Ltd.

Conclusion

Mi Jin Kim's work in developing pharmaceutical compositions for cancer treatment showcases her commitment to innovation in the medical field. Her contributions are vital in the ongoing fight against liver cancer, particularly in overcoming treatment resistance.